Roberta Marchione

Roberta Marchione currently serves as the Head of CMC at Alentis Therapeutics since March 2020, overseeing CMC, product development, and supply activities for pipeline products. Prior experience includes roles as CMC Lead, focusing on monoclonal antibodies, and as a Senior Scientist at Amal Therapeutics, where responsibilities encompassed managing CMC activities and supporting quality assurance. As an independent CMC consultant since November 2019, Roberta assists in biopharmaceutical development and regulatory documentation. Academic qualifications include a Ph.D. in Biotechnology from Université de Grenoble and a Master's degree in Cellular and Molecular Biology from Seconda Università degli Studi di Napoli.